2001 - Comparative Analysis of Patients’ Characteristics, Treatment, and Survival Outcomes in CLL from China and the US

Primary Author / Presenter(s)

YY

Yuting Yan, PhD

China
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China (People's Republic)

Co-Author(s)

YL

Yin Liu, MD

Department of Public Administration, China Pharmaceutical University
Nianjin, Jiangsu, China (People's Republic)
YY

Ying Yu, PhD

1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China； 2. Tianjin Institutes of Health Science，Tianjin 301600, China.
Tianjin, Tianjin, China (People's Republic)
WX

Wenjie Xiong, MD

1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China； 2. Tianjin Institutes of Health Science，Tianjin 301600, China.
Tianjin, China (People's Republic)
TW

Tingyu Wang, MD

1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China； 2. Tianjin Institutes of Health Science，Tianjin 301600, China.
Tianjin, Tianjin, China (People's Republic)
Lugui Qiu, PhD

Professor & Director, Department of Lymphoma & Myeloma
1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China； 2. Tianjin Institutes of Health Science，Tianjin 301600, China.
Tianjin, Tianjin, China (People's Republic)
JZ

Jifang Zhou, MD

Department of Public Administration, China Pharmaceutical Universit
Nanjing, Jiangsu, China (People's Republic)
SY

Shuhua Yi, PhD

1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China； 2. Tianjin Institutes of Health Science，Tianjin 301600, China.
Tianjin, Tianjin, China (People's Republic)